Rina Dalva Neubarth Giorgi

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry

Cláudia Diniz Lopes Marques, Adriana María Kakehasi, Marcelo Medeiros Pinheiro et al. · RMD Open · 2021 · 79 citations · Full text

Life Sciences, Clinical Sciences, Immunology +12

2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis

Lícia Maria Henrique da Mota, Adriana María Kakehasi, Ana Paula Monteiro Gomides et al. · Advances in Rheumatology · 2018 · 49 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil

Geraldo da Rocha Castelar Pinheiro, Ana Beatriz Vargas‐Santos, Cleandro Pires de Albuquerque et al. · Advances in Rheumatology · 2018 · 39 citations · Full text

Medicine, Health Sciences, Clinical Medicine +13

High Levels of Polypharmacy in Rheumatoid Arthritis—A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study

Ana Paula Monteiro Gomides, Cleandro Pires de Albuquerque, Ana Beatriz Vargas‐Santos et al. · Journal of Pharmacy Practice · 2019 · 39 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Discordance between the patient’s and physician’s global assessment in rheumatoid arthritis: Data from the REAL study—Brazil

Maria Fernanda Brandão de Resende Guimarães, Maria Raquel da Costa Pinto, Gustavo Gomes Resende et al. · PLoS ONE · 2020 · 38 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9